Why a universal antiretroviral regimen?
Charles W Flexner, Polly Clayden, Willem D F Venter
Author Information
- Charles W Flexner: aDivisions of Clinical Pharmacology and Infectious Diseases, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA bHIV-Base, London, UK cWits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
No abstract text available.
- Curr Opin HIV AIDS. 2017 Jul;12 (4):334-338
[PMID: 28403026]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):377-382
[PMID: 28570369]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):398-402
[PMID: 28463853]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):408-413
[PMID: 28562507]
- AIDS. 2016 Nov 28;30(18):2831-2834
[PMID: 27824625]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):343-350
[PMID: 28368868]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):390-397
[PMID: 28441147]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):403-407
[PMID: 28383299]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):414-422
[PMID: 28410249]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):324-333
[PMID: 28403027]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):351-354
[PMID: 28538284]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):383-389
[PMID: 28509712]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):359-368
[PMID: 28426519]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):339-342
[PMID: 28570367]
- N Engl J Med. 2016 Sep 1;375(9):830-9
[PMID: 27424812]
- Curr Opin HIV AIDS. 2017 Jul;12 (4):355-358
[PMID: 28403028]
- R24 AI118397/NIAID NIH HHS
- U01 AI069465/NIAID NIH HHS
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active
Global Health
HIV Infections
Humans
